Generic Opana ER gets FDA OK

07/15/2013 | RTT News · Benzinga.com

The FDA has granted Actavis approval for its oxymorphone hydrochloride extended-release tablets in five strengths to treat moderate to severe pain in patients who need continuous around-the-clock opioid treatment. The drug is a generic version of Opana ER, made by Endo Health Solutions.

View Full Article in:

RTT News · Benzinga.com

Published in Brief: